Researchers identify the mechanisms behind tricyclic antidepressants' ability to help relieve nerve pain.
A new substance named Lu AF60097 may help reduce side effects from tricyclic antidepressants in those with severe depression.
Researchers have identified a link between depression, antidepressant use and an increased risk of developing venous thromboembolism.
Researchers propose a variety of therapeutic approaches and medications to help combat adult nightmare disorder.
According to researchers, an antidepressant that has been available for more than 50 years could help slow the progression of Parkinson's disease. The drug, nortiptyline, has been shown to stop the growth of alpha synuclein.
A new study reports an antidepressant temporarily inhibits the blood-brain barrier, allowing drugs to enter the brain. The findings could have implications for treating neurological diseases from ALS to epilepsy.
According to researchers, combining tricyclic antidepressants with blood thinners increased tumor autophagy in mouse models of glioblastoma brain cancer.
Researchers believe the newly understood mechanism could yield insights into more precise future treatments for nerve pain and depression.
